Get started
Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc.Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc.

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsETFs
Full chart
Full chart

Compare with Eloxx Pharmaceuticals, Inc.



Key stats


Market capitalization
‪64.58 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−6.00 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪3.06 M‬
Beta (1Y)
‪−2.24 K‬

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
10
Change (1Y)
−8−44.44%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−599.50 K‬ USD

Company info


Sector
Health Technology
Industry
Biotechnology
CEO
Sumit Aggarwal
Website
eloxxpharma.com
Headquarters
Arlington
Founded
2017
IPO date
Jun 9, 2026
IPO offer price
11.00 USD
ISIN
US29014R3012
CUSIP
29014R301
FIGI
BBG000BGGWS3
Identifiers
ISIN US29014R3012
CFI code
ESVUFR
Eloxx Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of novel ribonucleic acid-modulating drug candidates. It focuses on the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Arlington, MA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

ETFs holding the stock


CCUS
Counterpoint Global CIBC U.S. Small Cap Growth ETF Trust Units
Weight0.26%
Market value‪2.48 K‬

Explore more ETFs 

Frequently asked questions


The current price of ELOX is 15.07 USD — it has decreased by −5.81% in the past 24 hours. Watch Eloxx Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Eloxx Pharmaceuticals, Inc. stocks are traded under the ticker ELOX.
ELOX stock has fallen by −20.68% compared to the previous week, the month change is a 12.80% rise, over the last year Eloxx Pharmaceuticals, Inc. has showed a ‪1.37 M‬% increase.
We've gathered analysts' opinions on Eloxx Pharmaceuticals, Inc. future price: according to them, ELOX price has a max estimate of 43.00 USD and a min estimate of 38.00 USD. Watch ELOX chart and read a more detailed Eloxx Pharmaceuticals, Inc. stock forecast: see what analysts think of Eloxx Pharmaceuticals, Inc. and suggest that you do with its stocks.
ELOX reached its all-time high on Oct 7, 1999 with the price of 45,100,000.00 USD, and its all-time low was 0.000011 USD and was reached on Aug 14, 2024. View more price dynamics on ELOX chart.
See other stocks reaching their highest and lowest prices.
ELOX stock is 11.50% volatile and has beta coefficient of ‪−2.24 K‬. Track Eloxx Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Eloxx Pharmaceuticals, Inc. there?
Today Eloxx Pharmaceuticals, Inc. has the market capitalization of ‪64.58 M‬, it has increased by 6.25% over the last week.
Yes, you can track Eloxx Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Eloxx Pharmaceuticals, Inc. is going to release the next earnings report on Nov 11, 2026. Keep track of upcoming events with our Earnings Calendar.
ELOX net income for the last quarter is ‪−4.50 M‬ USD, while the quarter before that showed ‪−3.75 M‬ USD of net income which accounts for 0.00% change. Track more Eloxx Pharmaceuticals, Inc. financial stats to get the full picture.
No, ELOX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Aug 29, 2026, the company has 10 employees. See our rating of the largest employees — is Eloxx Pharmaceuticals, Inc. on this list?
Like other stocks, ELOX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eloxx Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.